書籍詳細

総論

P.10 掲載の参考文献

• 1) Rose VL:American Thoracic Society issues consensus statement on dyspnea. Am Fam Physician 59:3259-3260, 1999
  pubmed

• 2) Pratter MR, Curley FJ, Dubois J, et al:Cause and evaluation of chronic dyspnea in a pulmonary disease clinic. Arch Intern Med 149:2277-2282, 1989

• 3) Manning HL, Schwartzstein RM:Pathophysiology of dyspnea. N Engl J Med 333:1547-1553, 1995
  pubmed

• 4) Klinkman MS, Stevens D, Gorenflo DW:Episodes of care for chest pain:a preliminary report from MIRNET. Michigan Research Network J Fam Pract 38:345-352, 1994

• 5) Svavarsdottir AE, Jonasson MR, Gudmundssoll GH, et al:Chest pain in family practice. Diagnosis and long-term outcome in a community setting. Can Fam Physician 42:1122-1128, 1996

• 6) Thompson AB, Teschler H, Rennard SI:Pathogenesis, evaluation, and therapy for massive hemoptysis. Clin Chest Med 13169-82, 1992

• 7) Hirshberg B, Biran I, Glazer M, et al:Hemoptysis:Etiology, evaluation, and outcome in a tertiary referral hospital. Chest 112:440-444, 1997

• 8) Cahill BC, Ingbar DH:Massive hemoptysis. Assessment and management. Clin Chest Med 15:147-167, 1997

P.16 掲載の参考文献

• 1) 林 邦昭, 中田 肇編:胸部単純X線診断-画像の成り立ちと読影の進め方. 秀潤社, 東京, 2000

• 2) 高橋睦正編:必修放射線医学, 第4版, 南江堂, 東京, 1999

• 3) 中田 肇, 伊藤春海編:胸部CT-読影と診断のテキスト, 第3版, 秀潤社, 東京,

• 4) 中村克己, 中田 肇:胸部X線診断:その効用と限界, 未来. 疾患と鑑別すべき正常または正常変異. 臨床画像18:86-92, 2002

• 5) 渡辺秀幸, 中田 肇:胸部単純X線診断-検査法と読影の要点-正常X線解剖. 画像診断19:368-377, 1999

• 6) 中田 肇:胸部X線検査における側面像の活用. 呼吸14:35-39, 1995

P.20 掲載の参考文献

• 1) Murata K, Khan A, Herman PG:Pulmonary parenchymal disease;Evalation with high resolution CT. Radiology 170:629-635, 1989

• 2) Itoh H, Murata K, Konishi J, et al:Diffuse lung disease; Pathologic basis for the high-resolution Computed tomography findings. J Thorac Imag 8:176-188, 1993

• 3) Reid L:The secondary lobule in the adult human lung with special refference to its appearance in bronchograms. Thorax 13:110-115, 1958

• 4) Miller WS:The lung, 2nd ed. p 245, Springfield, Charles C. Thomas, 1950

P.31 掲載の参考文献

• 1) 厚生省特定疾患「呼吸不全」調査研究班編集:呼吸不全診断と治療のためのガイドライン, メディカルレビュー社, 1996

• 2) 諏訪邦夫:呼吸不全の臨床と生理 改訂4版, 中外医学杜, 1997

• 3) Murray&Nadel:Textbook of Respiratory Medicine, 3rd ed, W. B. Saunders Company, 2000

• 4) Pennock BE:Pressure support ventilation with a simplified ventilatory support system administered with a nasal mask in patients with respiratory failure. Chest 100:1371-1376, 1991
  pubmed

• 5) Mehta S, Hill NS:Noninvasive Ventilation. Am J Respir Crit Care Med 163:540-577, 2001
  pubmed

• 6) 徳永 豊:特集急性呼吸不全をどうするか?COPDの急性増悪. 救急 集中治療13:327-333, 2001

• 7) MacIntyre NR:Evidence-based guidelines for weaning and discontinuing ventilator support:a collective task force facilitated by the American College of Chest Physicians;the American Association for Respiratory Care;and the American College of Critical Care Medicine. Chest 120:375S-95S, 2001

• 8) British Thoracic Society Standards of Care Committee. BTS GUIDELINE:Non-invasive ventilation in acute respiratory failure. Thorax 57:192-211, 2002

P.38 掲載の参考文献

• 1) 平賀俊尚, 西村正治, 宮本顕二ほか:慢性肺疾患患者の生存率と準呼吸不全の呼吸機能 肺循環動態の検討-右心カテーテル検査が施行された全国205例の追跡調査 (1990年)-. 厚生省特定疾患「呼吸不全調査研究班」平成2年度研究報告書75, 1991

• 2) Kawakami Y, Irie T, Kishi F:Criteria for pulmonary and respiratory failure in COPD patients-a theoretical study based on clinical data. Respiration 43:436-443, 1982
  pubmed

• 3) Official Statement of the American Thoracic Society. Standard for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152, part 2, 1995

• 4) Fletcher EC, Donner CF, Midgren B, et al:Survival in COPD patients with a daytime Pa02>60mm Hg with and without nocturnal oxyhemoglobin desaturation. Chest 101:649-655, 1992

• 5) 宮本顕二, 川上義和, 飛田 渉ほか:経済効果からみた在宅酸素療法の有用性. 厚生省特定疾患「呼吸不全調査研究班」平成 7年度研究報告書15, 1996

• 6) Okubadejo M, Paul EA, Jones PW, et al:Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia? Eur Respir J 9:2335-2339, 19961

P.43 掲載の参考文献

• 1) Barnes PJ:Anti-inflammatory actions of glucocorticoids:molecular mechanisms. Clinical Science 94:557-572, 1998
  pubmed

• 2) van der Velden V H J:Glucocorticoids:mechanisms of action and anti-inflammatory potential in asthma. Mediators of Inflammation 7:229-237, 1998

• 3) 安田圭吾編集:臨床各科でのステロイド薬の使い方, pp 1-265, 永井書店, 大阪, 2001

P.48 掲載の参考文献

• 1) Cooper JD, Patterson GA, Sundaresan RS, et al:Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 112:1319 1329, 1996

• 2) Date H, Goto K, Souda R, et al:Bilateral lung volume reduction surgery via median sternotomy for severe pulmonary emphysema. Ann Thorac Surg 65:939-942, 1998
  pubmed

• 3) Bingisser R, Zollinger A, Hauser M, et al:Bilateral volume reduction surgery for diffuse pulmonary emphysema by video-assisted thoracoscopy. J Thorac Cardiovasc Surg 112:875-882, 1996
  pubmed

• 4) The National Emphysema Treatment Trial Research Group:Rationale and design of the national emphysema treatment trial. A prospective randomized trial of lung volume reduction surgery. Chest 16:1750-1761, 1999

• 5) 清水信義, 伊達洋至, 山下素弘ほか:国内初の両側生体部分肺移植成功例. 日外会誌 100:806814, 1999

• 6) Miyoshi S, Minami M, Ohta M, et al:Single lung transplantation from a brain-dead donor for a patient with idiopathic pulmonary fibrosis. A breakthrough after new legislation in Japan. JJTCV 49:39&403, 2001

• 7) 松村輔二, 岡田克典, 佐渡 哲ほか:本邦初の脳死肺移植-右片肺移植-. 今日の移植 13:418-425, 2000

• 8) Date H, Sano Y, Aoe M, et al:Living-donor lobar lung transplantation for bronchiolitis obliterans after Stevens-Johnson syndrome. J Thorac Cardiovasc Surg 123:389-391, 2002
  pubmed

• 9) Starnes VA, Barr ML, Cohen RG, et al:Living-donor lobar lung transplantation experience. Intermediate results. J Thorac Cardiovasc Surg 112:1284-1290, 1996
  pubmed

• 10) Date H, Sano Y, Aoe M, et al:Living-donor single lobe lung transplantation for primary pulmonary hypertension in a child. J Thorac Cardiovasc Surg 123:1211-1213, 2002

P.53 掲載の参考文献

• 1) International Human Genome Sequencing Consortium:Initial sequencing and analysis of the human genome. Nature 409:860-921,2001
  pubmed

• 2) Venter JC, Adams MD, Myers EW, et al:The sequence of the human genome. Science 291:1304-1351,2001

• 3) OMIM(on-line mendelian inheritance in man:http://www.ncbi.nlm.nih.gov/Omim/

• 4) Hiyama K:Polymorphisms and respiratory diseases. In:Recent Research Developments in Human Genetics, pp333-352, Research Signpost, Kerala, India, 2003

• 5) 山口惠三,岩本愛吉編:日本臨牀増刊号「新世紀の感染症学」下巻,pp153-213,2003

疾患編

P.62 掲載の参考文献

• 1) 横山彰仁, 上田暢男, 平澤 泰ほか:気管支喘息治療における短期経口ステロイド薬使用の現状. 呼吸15:1450-1457, 1996

• 2) Weinberger M, Hendeles L:Theophylline in asthma. N Engl J Med 334:1380-1388, 1996
  pubmed

• 3) 厚生省免疫 アレルギー研究班:喘息予防 管理ガイドライン, 協和企画通信, 東京, 1998

• 4) Cookson W:The alliance of genes and environment in asthma and allergy. Nature 402 (6760 Suppl):B 5-11, 1999

• 5) 横山彰仁:Th2と気管支喘息. 分子呼吸器病 4:123-129, 2000
  Medical*Online

• 6) Kay AB:Allergy and allergic diseases. First of two parts. N Engl J Med 344:30-37, 2001 Second of two parts. N Engl J Med 344:109-113, 2001

• 7) Busse WW, Lemanske RF Jr:Asthma. N Engl J Med 344:350-362, 2001
  pubmed

• 8) Naureckas ET, Solway J:Clinical practice. Mild asthma. N Engl J Med 345:1257-1262, 2001
  pubmed

P.74 掲載の参考文献

• 1) Smith HL:BuckWheat poisoning;with report of a case in man. Arch Intern Med 3:350359, 1909

• 2) 三沢敬義:アレルギー性疾患. 日内会誌 25:133-262, 1937

• 3) 中村 晋, 室久敏三郎:気管支喘息の研究 第5報 そばアレルギーについて. アレルギー 19:702-717, 1970
  Medical*Online

• 4) 中村 晋:職業性喘息-研究の歴史 4. 喘息13:115-120, 2000

• 5) 小林節雄:わが国の職業喘息. 呼吸4:1000, 1985

• 6) Yamada K, Urisu A, Morita Y, et al:Immediate hypersensitive reactions to buck Wheat ingestion and cross allergenicity between buckwheat and rice antigens in subjects with high levels of IgE antibodies to buckwheat. Ann Allergy Asthma Immunol 75:56-61, 1995

• 7) 田中和子, 中島敏治, 斎藤博久:そばアレルギー. アレルギー科 9:25-30, 2000

P.79 掲載の参考文献

• 1) 滝沢 始, 伊藤幸治:アレルギー性気管支肺アスペルギルス症. 呼吸器疾患state of arts, pp 371-373, 医歯薬出版株式会社, 東京, 1994

• 2) Rosenberg M, Patterson R, Mintzer R, et al Clinical and immunologic criteria for the diagnosis of allergic bronchopulumonary aspergillosis. Ann Inter Med 86:405-414, 1977

• 3) Patterson R, Greenberger PA, Halwig JM, et al:Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 146:916-918, 1986
  pubmed

• 4) Patterson R, Greenberger PA, Radin RC, et al:Allergic bronchopulumonary aspergillosis:staging as an aid to management. Ann Inter Med 96:286-291, 1982

• 5) Greenberger PA, Patterson R:Diagnosis and management of allergic bronchopulmonary aspergillosis. Ann Allergy 56:444-448, 1986
  pubmed

• 6) Stevens DA, Schwartz HJ, Lee JY, et al:A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 342:756762, 2000

• 7) Imbeault B, Cormier Y:Usefulness of inhaled high-dose corticosteroids in allergic bronchopulmonary aspergillosis. Chest 103:1614-1617, 1993
  pubmed

• 8) Grancy JJ, Elder JL, McAleer R:Allergic bronchopulmonary fungal disease without clinical asthma. Thrax 36:345349, 1981

• 9) 松瀬厚人, 渡辺 尚, 藤原千鶴ほか:当院で経験したアレルギー性気管支肺アスペルギルス症6例の臨床的検討. 日胸疾会誌 32:836-842, 1994

• 10) 伊藤伸介, 島浩一郎, 佐藤浩一ほか:空洞陰影を呈し喘息症状を伴わなかったアレルギー性気管支肺アスペルギルス症の一例. 気管支学 14:85-91, 1992

• 11) 吉田ナガミ, 勝呂 元, 小原富士男ほか:気管支喘息をともなわないアレルギー性気管支肺アスペルギルス症の1例. 日胸疾会誌 30:2123-2127, 1992

• 12) 松瀬厚人, 藤原千鶴, 高尾真子ほか:気管支喘息を伴わないアレルギー性気管支肺アスペルギルス症の1例. 呼吸 13:1055-1059, 1994
  Medical*Online

• 13) 工藤宏一郎, 可部順三郎:肺アスペルギルス症の診断と治療. アレルギー性気管支肺アスペルギルス症 (ABPA) . 結核 72:91-98, 1997

• 14) Knutsen AP, Mueller KR, Hutcheson PS, et al:Serum anti-Aspergillus fumigatus antibodies by immunoblot and ELISA in cystic fibrosis with allergic bronchopulumonary aspergillosis. J Allergy Clin Immunol 93:926-931, 1994
  pubmed

• 15) Simmonds EJ, Littlewood JM, Evans EGV:Cystic fibrosis and allergic bronchopulumonary aspergillosis. Arch Dis Child 65:507-511, 1990

• 16) 久保雅子, 工藤宏一郎, 越野 健ほか:慢性気道感染を合併した喘息症状のないアレルギー性気管支肺アスペルギルス症の1例. 日本胸部疾患学会誌 35:110-116, 1997

P.88 掲載の参考文献

• 1) 日本呼吸器学会COPDガイドライン作成委員会編. 日本呼吸器学会COPDガイドライン:COPD (慢性閉塞性肺疾患) 診断 と治療のためのガイドラインメディカルレビュー社, 東京, 1999.

• 2) Global initiative for Chronic Obstructive Lung Disease:National Heart, Lung and Blood institute, national institutes of health. Publication number 2701, April 2001

P.97 掲載の参考文献

• 1) Gleeson K, Zwillich CW, White DP:The influence of increasing ventilatory effort on arousal from sleep. Am Rev Respir Dis 142:295-300, 1990
  pubmed

• 2) Chugh DC, Weaver TE, Dinges DF:Neurobehavioral consequences of arousals. Sleep 19:S 198-S 201, 1996

• 3) Guilleminault C:Clinical features and evaluation of obstnuctive sleep apnea. In:Principle&Practice of Sleep Medicine (ed Kryger MH, Roth T, Dement WC), 2nd ed, pp 667-377, Saunders, Philadelphia, 1994

• 4) Needleman P, Greenwald JE:Atriopeptin:a cardiac hormone intimately involved in fluid, electrolyte and blood pressure homeostasis. New Engl J Med 314:828-834, 1986

• 5) 高崎雄司:睡眠時無呼吸症候群:その臨床と疫学. 呼と循 49:1043-1048, 2001

• 6) Hudgel DW:The role of upper airway anatomy and physiology in obstructive sleep apnea. Clin Chest Med 13:383-395, 1992
  pubmed

• 7) He J, Kryger MH, Zorick FJ, et al:Mortality and apnea index in obstructive sleep apnea:Experience in 389 male patients. Chest 94:9-14, 1988

• 8) Sanders MH:Medical therapy for obstructive sleep apnea-hypopnea syndrome. In:Principles and Practice of Sleep Medicine (eds, Kryger MH, Roth T, Dement WC), 3rd ed, pp 879-893, Saunders, Philadelphia, 2000

• 9) Sullivan CE, Issa FG, Berthon-Jones M, et al:Reversal of obstuctive sleep apnea by continuous positive airway pressure applied through the nares. Lancet 1:862-865, 1981

• 10) 高崎雄司, 太田保世, 西村正治ほか:わが国の睡眠時無呼吸症候群-全国5医療機関によるSASの病態とnasal CPAP効果の 検討-. 日胸疾会誌 36:53-60, 1998

• 11) An American Academy of Sleep Medicine Report. Practice parameters for the use of auto-titrating pressures and treating adults patients with obstructive sleep apnea syndrome. Sleep 25:143-147, 2002
  pubmed

• 12) Waldhorn RE, Henick TW, Nguyen MC, et al:Long-term compliance with nasal continuous positive airway pressure therapy of sleep apnea. Chest 97:33-38, 1990

• 13) He J, Kryger MH, Zorick FJ, et al:Mortality and apnea index in obstructive sleep apnea (experience in 385 patients) . Chest 94:9 14, 1988

• 14) American Sleep Disorders Association Standards of Practice Committee, Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances. Sleep 18:511-513, 1995
  pubmed

• 15) Lowe AA, Schmidt-Nowara WW:Oral appliance therapy for snoring and sleep apnea. In:Sleep Apnea;Pathogenesis, Diagnosis, and Treatment (eds Pack AI), ppp 555-573, Dekker, New York, 2002

• 16) Sher AE, Goldberg AN:Upper airway surgery for obstructive sleep apnea, In:Sleep Apnea:Pathogenesis, Diagnosis, and Treatment (eds Pack AI), pp 575-605, Dekker, New York, 2002

• 17) 高崎雄司:中枢型睡眠時無呼吸, Annual Review呼吸器1995 (太田保世, 諏訪邦夫, 堀江孝至, 他編) , pp 1-7, 1994

• 18) Bradley TD, Phillipson EA:Central sleep apnea. Clin Chest Med 13:493-505, 1992
  pubmed

• 19) 高崎雄司, 神尾和孝, 小野容明ほか:非挿管下人工換気, 特にNIPPVによる呼吸管理, 非観血的補助呼吸の効果発現病態-左心不全とII型呼吸不全について. 日胸疾会誌 35:132-138, 1997

• 20) Bonnet MH, Dexter JR, Arand DL:The effect of triazelam on arousal and respiration in central sleep apnea patients. Sleep 13:31-41, 1990
  pubmed

• 21) Javaheri S, Parker TJ, Liming JD, et al:Sleep apnea in 81 ambulatory male patients with stable heart failure. Circulation 97:2154-2159, 1998
  pubmed

• 22) Takasaki Y, et al:Effect of nasal continuous positive airway pressure on sleep apnea in congestive heart failure. Am Rev Respir Dis 140:152&1534, 1989

• 23) Naughton MT, Bradley TD:Sleep apnea in congestive heart failure. Clin Chest Med 19:99-113, 1998

• 24) Javaheri S:Effect of continuos positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 101:392-397, 2000

P.98 掲載の参考文献

• 25) 高崎雄司ほか:閉塞型睡眠時無呼吸症候群 (OSA) におけるCPAPの脂質代謝に対する3ないし6ヶ月継続効果の検討. 日呼会誌 (in press.)

P.103 掲載の参考文献

• 1) 下方 薫:気胸, 新臨床内科学, 第8版 (I), p 364, 医学書院, 東京, 2002

• 2) Light RW:Pneumothorax, in Pleural diseases, 3rd ed, p 242, Williams&Wilkins Baltimore, 1995

• 3) Sahn SA, Hefiner JE:Spontaneous pneumothorax. N Eng J Med 342:868, 2000

• 4) Cardillo G, Facciolo F, Giunti R, et al:Videothoracoscopic treatment of promary spontaneous pneumothorax:a 6year experience. Ann Thorac Surg 69:357, 2000

• 5) Hatz RA, Kaps MF, Meimarakis G, et al:Long term results after video-assisted thoracoscopic surgery for first-time and recurrent spontaneous pneumothorax. Ann Thorac Surg 70:253, 2000
  pubmed

• 6) 岡林 寛, 平塚昌文, 前川信一ほか:自然気胸の現状と展望. 呼吸21:304, 2002

• 7) Sadikot Rr, Greene T, Meadows K, et al:Recurrence of primary spontaneous pneumothorax. Thorax 52:805, 1997

• 8) Baumann MH, Strange C, Heffner JE, et al:Management of spontaneous pneumothorax:an American College of Chest Physitians Delphi consensus statement. Chest 119:590, 2001

P.108 掲載の参考文献

• 1) Advanced Trauma Life Support Course. American College of Surgeons Committee on Trauma, pp 11-24, Chicago, 1988

• 2) Barton ED:Tension pneumothorax. Curr Opin Pulm Med 5:269-274, 1999
  pubmed

• 3) American Heart Association, Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 102:1-150-1-152, 2000

• 4) 国民衛生の動向. 2000年第47巻第9号, 厚生統計協

P.112 掲載の参考文献

• 1) 大里外誉郎編:医科ウイルス学. p 467, 南江堂, 東京, 2000

• 2) 永井寛之, 那須 勝:かぜの一般対症療法. 臨床と研究 77:2250-2255, 2000
  Medical*Online

• 3) 山谷睦雄:呼吸器ウイルス感染症の病態と治療. 呼吸 17:1124-1136, 1998
  Medical*Online

• 4) Leier CV:in Atlas of Heart Disease, p 92, Current Medicine, Philadelphia, 1995

• 5) 門田淳-, 河野 茂:抗菌療法の適応とタイミング. 臨床と研究 77:22662269, 2000

• 6) 石田直:呼吸器感染症の起炎病原体. 化学療法の領域 16:1023-1028, 2000

• 7) 副島林造:Chlamydia pneumoniae呼吸器感染症の基礎と臨床, 第35回日本胸部疾患学会総会教育セミナー講演記録集, pp 277-287, 胸部疾患学会, 東京T 1995

• 8) 宮下修行, 深野浩史, 松島敏春:Chlamydia pneumoniae感染症と動脈硬化. 日本内科学会雑誌90:2405-2412, 2001

• 9) 黒崎知道:耐性肺炎球菌感染症. 小児科臨床55:637-644, 2002

P.117 掲載の参考文献

• 1) 日本呼吸器学会市中肺炎診療ガイドライン作成委員会:成人市中肺炎診療の考え方, 日本呼吸器学会, 東京, 2000

P.122 掲載の参考文献

• 1) Miyashita N, Fukano H, Niki Y, et al:Etiology of community-acquired pneumonia requiring hospitalization in Japan. Chest 119:1295-1296, 2001
  pubmed

• 2) Miyashita N, Fukano H, Yoshida K, et al:Seroepidemiology of Chlamydia pneumoniae in Japan between 1991 and 2000. J Clin Pathol 55:115-117, 2002
  pubmed

• 3) Miyashita N, Fukano H, Okimoto N, et al:Clinical presentation of community-acquired Chlamydia pneumoniae pneumonia in adults. Chest 121:1776-1781, 2002
  pubmed

• 4) Miyashita N, Niki Y, Nakajima M, et al:Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults. Chest 119:1416-1419, 2001
  pubmed

• 5) Miyashita N, Fukano H, Hara H, et al:Recurrent pneumonia due to persistent Chlamydia pneumoniae infection. Intern Med 41:30-33, 2002
  pubmed

• 6) Miyashita N, Kubota Y, Nakajima M, et al:Chlamydia pneumoniae and exacerbations of asthma in adults. Ann Allergy Asthma Immunol 80:405-409, 1998
  pubmed

• 7) Miyashita N, Niki Y, Nakajima M, et al:Chlamydia pneumoniae infection in patients with diffuse panbronchiolitis and COPD. Chest 114:969-971, 1998
  pubmed

• 8) Miyashita N, Matsumoto A, Kubota Y, et al:Continuous isolation and characterization of Chlamydia pneumoniae from a patient with diffuse panbronchilitis. Microbiol Immunol 40:547-552, 1996

• 9) Miyashita N, Niki Y, Kishimoto T, et al:In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp. Antimicrob Agents Chemother 41:1331-1334, 1997
  pubmed

• 10) Miyashita N, Niki Y, Matsushima T, et al:In vitro and in vivo activities of sitafloxacin against Chlamydia spp. Antimicrob Agents Chemother 45:3270-3272, 2001
  pubmed

• 11) Miyashita N, Fukano H, Niki Y, et al:In vitro activitiy of telithromycin, a new ketolide, against Chlamydia pneumoniae. J Antimicrob Chemother 48:403-405, 2001

P.136 掲載の参考文献

• 1) Edman LC, Kovacs LA, Masur H, et al:Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 334:519-522, 1988

• 2) Matsumoto Y, Matsuda S, Tegoshi T:Yeast glucan in the cyst wall of Pneumocystis carinii. J Protozool 36:21S-22S, 1989
  pubmed

• 3) Kuhlman JE:Pneumocystic infections:the radiologist's perpective. Radiology 198:623-635, 1996

• 4) 安岡 彰:ニューモシスチス カリニ肺炎. 診断と治療 87:2176-2181, 1999
  Medical*Online

• 5) 工藤翔二, 臼杵二郎:ニューモシスチス カリニ肺炎. 臨床と微生物 20:960-964, 1993
  Medical*Online

• 6) 伊志嶺朝彦, 仲本 敦, 斉藤 厚ほか:Pneumocystis carinii肺炎の早期診断におけるpolymerase chain reaction (PCR) 法の有用性に関する研究. 感染症誌 68:451-453, 1994

• 7) 鳥羽 剛:ニューモシスチス カリニ肺炎. 小児内科28:77-81, 1996

• 8) Bye MR, Cairns-Bazarian AM, Ewig JM:Markedly reduced mortality associated with corticosteroid therapy of Pnemocystiscarinii pneumonia in children with acquired immunodeficiency syndrome. Arch Pediatr Adolesc Med 148:63&641, 1994

• 9) 田邉一成:CMV感染症の診断法. 臓器移植におけるサイトメガロウイルス感染症, pp 19-35, 日本医学館, 東京, 1997

• 10) Fraser RS, Muller NL, Colman N, et al:Cytomegalovirus. In:Diagnosis of disease of the chest (Ed, Fraser RS, et al), pp 1004-1008, WB Saunders Company, Philadelphia, 1999

• 11) Kang EY, Petz Jr FF, Muller NL, et al:Cytomegalovirus pneumonia in transplant patients:CT findings. J Comput Assist Tomogr 20:295-299, 1996

• 12) Aafedt BC, Halvorsen RA, Tylen U, et al:Cytomegalovirus pneumonia:computed tomography findings. J Can Assoc Radiol 41:276-280, 1990

• 13) McGuinness G, Scholes JV, Garay SM, et al:Cytomegalovirus pneumonitis:spectrum of parenchymal CT findings with pathologic correlation in 21 AIDS patients. Radiology 192:451-459, 1994
  pubmed

• 14) 田代隆良, 後藤陽-郎, 重野秀明ほか:サイトメガロウイルス感染症の臨床病理学的研究. 感染症誌63:1171-1177, 1989

• 15) 本田順一, 大泉耕太郎:治療の実際 サイトメガロウイルス肺炎. 臨床と研究77:6972, 2000

• 16) van den Berg AP, van der Bij W, van Son WJ, et al:Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation-A report of 130 consecutive patients. Transplantation 48:991, 1989
  pubmed

• 17) 数田良宏, 鈴木修三, 高野 真ほか:膠原病治療中に発症したカリニ肺炎の検討. アレルギー 49:948, 2000
  Medical*Online

• 18) 照屋勝治, 岡 慎一:治療の実際 カリニ肺炎. 臨床と研究77:62-68, 2000

• 19) 知花なおみ, 相良博典, 福島康次ほか:当院におけるカリニ肺炎の臨床的検討. 日本呼吸器学会雑誌 38:221, 2000

• 20) Endresz V, Kari L, Berencsi K, et al:Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization. Vaccine 17:50-58, 1999

P.142 掲載の参考文献

• 1) Finegold SM:Lung abscess. In;Principle and practice of Infectious Diseases (ed, Mandell GL, et al), Churchill Livingstone, Philadelphia, 2000

• 2) Bartlett JG, Rosenblatt JE, Finegold SM:Percutaneous transtracheal aspiration in the diagnosis of anaerobic pulmonary infection. Ann Intern Med 79:535-540, 1973
  pubmed

• 3) Wimberly NW, Bass Jr JB, Boyd BW, et al:Use of a bronchoscopic protected catheter brush for the diagnosis of pulmonary infections. Chest 81:556-562, 1982

• 4) Broughton WA, Green AE, Hall MW, et al:The technique of protected brush catheter bronchoscopy. J Crit 1112:63-70, 1987

• 5) Sosenko A, Glassroth J:Fiberoptic bronchoscopy in the evaluation of lung abscess. Chest 87:489-494, 1985
  pubmed

P.148 掲載の参考文献

• 1) 茂木 孝, 木田厚瑞:気管支拡張症. 呼吸器疾患-State of Arts-, pp 550-553, 医歯薬出版, 東京, 1999

• 2) Morehead RS:Bronchiectasis on bone marrow transplantation. Thorax 52:392-393, 1997

• 3) Reid LM:Reduction in bronchial subdivision in bronchiectasis. Thorax 5:233-247, 1995

• 4) Loubeyre P, Paret M, Revel D, et al:Thin-section Ct detection of emphysema associated with bronchiectasis and correlation With pulmonary function tests. Chest 109:360-365, 1996
  pubmed

• 5) 小林琢哉:気管支拡張症. 画像診断別冊-びまん性肺疾患の高分解能CT (酒井文和他編), 秀潤社, 東京, 1998

• 6) Keistinen T, Saynajakangas D, Tumponen T, et al:Bronchiectasis:and orphan disease with a poorly-understood prognosis. Eur Respir J 10:2784-2787, 1997

P.154 掲載の参考文献

• 1) 日本結核病学会教育委員会:結核症の基礎知識. 結核 72:523 545, 1997

• 2) 伊藤正己:注目される感染症, 結核. 臨床科学 33:1132-1139, 1997

• 3) 小倉 剛:プライマリーケアからみた結核症. 内科学会雑誌 89:257-263, 2000

• 4) 露口泉夫:結核の免疫 (改訂版), (財) 結核予防会, 1998

• 5) 日本結核病学会抗酸菌検査法検討委員会編 (阿部千代治監修):新結核菌検査指針2000, (財) 結核予防会, 2000

• 6) 厚生省保健医療局エイズ結核感染症課監修:結核医療の基準とその解説, (財) 結核予防会, 1996

P.170 掲載の参考文献

• 1) 工藤翔二:特発性間質性肺炎の概念に関するわが国の歴史と課題. 日胸 60:487-494, 2001
  Medical*Online

• 2) 長井苑子:特発性間質性肺炎の概念と分類をめぐる最近の動向. 日胸 60:495-504, 2001
  Medical*Online

• 3) 河野修興, 近藤圭一:間質性肺炎の血清マーカー, KL-6, SP-A, SP-Dの診断的意義. 最新医学 56:2521-2528, 2001
  Medical*Online

P.175 掲載の参考文献

• 1) Oh J, Bailin T, Fukai K, et al:Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles. Nat Genet 14:300-306, 1996
  pubmed

• 2) Dell'Angelica EC, Shotelersuk Y, Aguilar RC, et al:Altered trafficking of lysosomal proteions in Hermansky-Pudlak syndrome due to mutations in the beta-3A subunit of the AP-3 adaptor. Mol Cell 3:11-21, 1999

• 3) Anikster Y, Huizing M, White J, et al:Mutation of a new gene causes a unique form of Hermansky-Pudlak syndrome in a genetic isolate of central Puerito Rico. Nat Genet 28:376-380, 2001

• 4) Suzuki T, Li W, Zhang Q, et al:Hermansky-Pudlak syndrome is caused by mutations in HPS 4, the human homolog of the mouse light-ear gene. Nat Genet 30:321-324, 2002

P.181 掲載の参考文献

• 1) Ando M, Arima K, Yoneda R, et al:Japanese summer-type hypersensitivity pneumonitis:geographic distribution, home environment, and clinical characteristics of 621 cases. Am Rev Respir Dis 144:765769, 1991

• 2) Shimazu K, Ando M, Sakata T, et al:Hypersensitivity pneumonitis induced by Trichosporon cutaneum. Am Rev Respir Dis 130:407-411, 1984
  pubmed

• 3) Mizobe T, Ando M, Yamasaki H, et al:Purification and characterization of the serotype-specific polysaccharide antigen of Trichosporon cutaneum serotype II:A disease-related antigen of Japanese summer-type hypersensitivity pneumonitis. Clin Exp Allergy 25:265-272, 1995

• 4) Ando M, Sakata T, Yoshida K, et al:Serotype-related antigen of Trichosporon cutaneum in the induction of summer-type hypersensitivity pneumonitis:correlation between serotype of inhalation challenge positive antigen and that of the isolates from patients'homes. J Allergy Clin Immunol 85:3644, 1990

• 5) Ando M, Yoshida K, Soda K, et al:Specific bronchoalveolar lavage IgA antibody in patients with summer-type hypersensitivity pneumonitis induced by Trichosporon cutaneum. Am Rev Respir Dis 134:177-179, 1986
  pubmed

• 6) Soda K, Ando M, Shimazu K, et al:Different classes of antibody activities to Trichosporon cutaneum antigen in summer-type hypersensitivity pneumonitis by enzyme-linked immunosorbent assay. Am Rev Respir Dis 133:83-87, 1986

• 7) Soda K, Ando M, Sakata T, et al:C 1q and C 3 in bronchoalveolar lavage fiuid from patients with summer-type hypersensitivity pneumonitis. Chest 93:7680, 1988

• 8) Yamasaki H, Kinoshita T, Ohmura T, et al:Lowered responsiveness of bronchoalveolar lavage T lymphocytes in hypersensitivity pneumonitis. Am J Respir Cell Mol Biol 4:417-425, 1991
  pubmed

• 9) Ando M, Hirayama K, Soda K, et al:HLA-DQw 3 in Japanese summer-type hypersensitivity pneumonitis induced by Trichosporon cutaneum. Am Rev Respir Dis 140:948950, 1989

• 10) Arima K Ando M, Ito K, et al:Effect of cigarette smoking on the prevalence of summer-type hypersensitivity pneumonitis caused by Trichosporn cutaneum. Archiev Environ Health 47:274-278, 1992

• 11) Yoshida K, Ando M, Sakata T, et al:Prevention of summer-type hypersensitivity pneumonitis:effect of elimination of Trichosporon cutaneum from the patient's homes. Arch Environ Health 44:317-322, 1989

• 12) Yamasaki H, Ando M, Brazer W, et al:Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis. J Immunol 163:3516-3523, 1999.
  pubmed

P.188 掲載の参考文献

• 1) Newman LS, Rose CS, Maier LA:Sarcoidosis. New Eng J Med 336:1224-1234, 1997
  pubmed

• 2) Hunninghake G:Statement on sarcoidosis. Am J Respir Crit Care Med 160:736755, 1999

• 3) Kobayashi J, Kitamura S:Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis. Chest 109:1276-1282, 1996
  pubmed

• 3) Hutchinson J:Illustration of clinical surgery, p 42, J&A Churchill, London, 1877

• 4) Ishige I, Usui Y, Takemura T, et al:Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 354:120-123, 1999
  pubmed

• 5) Nakata Y, Kataoka M, Ejiri T, et al:The response of alveolar lymphocytes induced by Propionibacterium acnes (P. acnes) in pulmonary sarcoidosis. Nihon Kyobu Sikkan Gakkai Zasshi 27:837-41, 1989

• 6) Abe C, Iwai K, Mikami R, et al:Frequent isolation of Propionibacterium acnes from sarcoidosis lymph nodes. Zbl Bakt Hyg 256:541-547, 1984

• 7) Askling J, Grunewald J, Eklund A, et al:Incresed risk for cancer following sarcoidosis. Am J Respir Crit care Med 160:1668-1672, 1999

• 8) Nunley DR, Hattler B, Keenan RJ, et al:Lung transplantation for end-stage pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16:93-100, 1999
  pubmed

P.193 掲載の参考文献

• 1) 労働省安全衛生部労働衛生課編:じん肺診査ハンドブック, 中央労働災害防止協会, 1980

• 2) Caplan A, Payne R Withey J:A broader concept of Caplan's syndrome related to rheumatoid factors. Thorax 17:205-212, 1962
  pubmed

• 3) 和田 攻:化学物質による肺障害. 臨床呼吸器病学 (原澤道美編), p 611, 朝倉書店, 1982

P.199 掲載の参考文献

• 1) Cox JD, Azarnia N, Byhardt RW, et al:A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79. 2 Gy:possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma:report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 8:1543-1555, 1990
  pubmed

• 2) Cox JD, Azarnia N, Byhardt RW, et al:N 2 (clinical) non-small cell carcinoma of the lung:prospective trials of radiation therapy with total doses 60 Gy by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 20:7-12, 1991

• 3) Pass HI, Mitchell JB, Johnson DH, et al:Lung cancer principles and practice, 2nd ed, Philadelphia, Lippincott Williams & Wilkins, 2000

• 4) Kohno N, Hamada H, Fujioka S, et al:Circulating antigen KL-6 and lactate dehydrogenase for monitoring irradiated patients with lung cancer. Chest 102:117-122, 1992
  pubmed

• 5) Hamada H, Kohno N, Akiyama M, et al:Monitoring of serum KL-6 antigen in a patient with radiation pneumonia. Chest 101:858-60, 1992

• 6) Goto K, Nishiwaki Y, Yokoyama A, et al:Serum levels of KL-6, surfactant proteins A and D are useful biomarkers for severe radiation pneumonitis. Jpn J Chest Disease 61:115-124, 2002

• 7) Goto K, Kodama T, Sekine I, et al:Serum levels of KL-6 are useful biomarkers for severe radiation pneumonitis. Lung Cancer 34:141-148, 2001
  pubmed

• 8) Takahashi H, Imai Y, Fujishima T, et al:Diagnostic significance of surfactant proteins A and D in sera from patients with radiation pneumonitis. Eur Respir J 17:481-487, 2001

• 9) Vujaskovic Z, Groen HJ:TGF-beta, radiation-induced pulmonary injury and lung cancer. Int J Radiat Biol 76:511-516, 2000
  pubmed

• 10) Anscher MS, Kong FM, Andrews K, et al:Plasma transforming growth factor betal as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 41:1029-1035, 1998

• 11) Anscher MS, Kong FM, Jirtle RL:The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy. Lung Cancer 19:109-120, 1998

• 12) Anscher MS, Marks LB, Shafman TD, et al:Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. J Clin Oncol 19:3758-3765, 2001

• 13) Hong JH, Chiang CS, Tsao CY, et al:Rapid induction of cytokine gene expression in the lung after single and fractionated doses of radiation. Int J Radiat Biol 75:1421-1427, 1999
  pubmed

• 14) Redlich CA, Gao X, Rockwell S, et al IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J Immunol 157:1705-1710, 1996
  pubmed

P.211 掲載の参考文献

• 1) Hull RD, Hirsh J, Carter CJ, et al:Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med 98:891-899, 1983
  pubmed

• 2) 佐藤徹:胸部X線写真. 肺血栓塞栓症の臨床 (国枝武義, 由谷親夫編), pp 48-63 , 医学書院, 東京, 1999

• 3) Miniati M, Prediletto R, Formichi B, et al:Accuracy of clinical assessment in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med 159:864-871, 1999
  pubmed

• 4) 岡田泰昌, 桑名俊一, 佐藤 徹ほか:血液ガス. II診断の進歩. 急性肺動脈血栓塞栓症. 日本内科会誌 90:233-241, 2001

• 5) Nagaya N, Uematsu M, Satoh T, et al:Serum uric acid levels correlate With the severity and the mortality of primary pulmonary hypertension. Am J Respir Crit Care Med 160:487-492, 1999
  pubmed

• 6) Nagaya N, Nishikimi T, Okano Y, et al:Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 31:202-208, 1998

• 7) Hirsh J, Hoak J:Approach to diagnosis of pulmonary embolism. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation With the Council on Cardiovascular Radiology), American Heart Association. Circulation 93:2219-2221, 1996

• 8) Raschke RA, Reilly BM, Guidry JR, et al:The weight-based heparin dosing nomogram compared With a standart care nomogram:arandomized controlled trial. Ann Intern Med 119:874-881, 1993

• 9) Hirsh J, Hoak J:Management of deep vein thrombosis and pulmonary embolism. Circulation 93:2212-2245, 1996
  pubmed